Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cyclic limulus anti- lipopolysaccharide (lps) factor derived peptide shows a novel way to attenuate tnf-a production induced by lps

  • At: 2010 FIP Congress in Lisbon (Portugal)
  • Type: Poster
  • By: XIA, Peiyuan (Dept. of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, China)
  • Co-author(s): Liu, Yao (Dept. of Pharmacy, Southwest Hospital, Third Military Medical University, CHONGQING, China)
    Ren, Jiandong (Dept. of Pharmacy, Southwest Hospital, Third Military Medical University, CHONGQING, China)
  • Abstract:

    CLP-19, a cyclic peptide derived from Limulus anti-LPS factor (LALF) which can neutralize LPS in vitro and in vivo. In this study, we show CLP-19 attenuate TNF-a production induced by LPS a novel way. Real-time PCR and ELISA analyses indicated that CLP-19 could suppress LPS-induced expression of TNF-a mRNA and protein by RAW264.7 cells. ELISA

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses